Evaluation at 5 and 10 Years of Renal Transplant Patients
ConditionTransplant; Complication, Failure
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Brest
About this trial
5 and 10 years follow-up of the oxyop study.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
informed patients participating to the oxyop study
Patient having completed the OXYOP M12 follow-up visit
Patient agreeing to participate in the observational study
Disqualifiers
Opposition to the use his medical data
patient deceased or with graft lost before M48
Trial population
116 patients previously included in the oxyop study
Trial design
Design model
Case-control
Time perspective
Retrospective
Treatments tested in this trial
Not listed
Trial groups
116 Participants
are grouped into 2 trial groupsGroup A: interventional group
Group B: control group
Trial outcomes
Primary outcomes
1
eGFR
estimated GFR (CKDEPI)
Time frame
10 yearsSecondary outcomes
1
patient survival
patient survival at last follow-up
Time frame
5 and 10 years2
graft survival
graft survival at last follow-up
Time frame
5 and 10 years3
rejection rate
biopsy proven rejection
Time frame
5 and 10 years4
infection rate
all infection episodes
Time frame
5 and 10 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: